Creatine has quietly become the supplement that people over 50 ask about most, and for once the interest is not entirely manufactured by marketing. There is a real body of research behind creatine for healthy aging, some of it genuinely encouraging, some of it flatly negative, and a lot of it more complicated than the headlines suggest.
Here is the short version. If you are an older adult who lifts weights, creatine has moderate quality evidence behind it for slightly bigger strength gains. For brain health, the evidence is promising but thin and contested, and Europe’s food safety regulator recently declined to approve a cognitive claim after looking at all of it. For bone density, two of the longest and best trials ever run found nothing. For fatigue under sleep loss, the results are striking but came from single experimental doses far above anything you would take daily. For male fertility and heart health, the honest answer is that the research is only just beginning. The rest of this article walks through each of those claims with the actual studies, doses and populations attached, because that is the only way to judge any of it.
What the Evidence Actually Shows
Creatine is a compound your liver, kidneys and pancreas make from amino acids, and it sits at the center of how cells regenerate ATP, the molecule that powers nearly everything a cell does. Muscle holds about 95 percent of it. The brain holds most of the rest, and the brain is an expensive organ to run, which is why researchers started wondering decades ago whether topping up creatine stores might matter more as we age.
The strongest and most consistent finding is about muscle. A 2026 systematic review and three level meta analysis of eleven randomized controlled trials in adults aged 60 and older found that creatine combined with resistance training improved muscle strength compared with resistance training alone, with a small effect size of g equals 0.31 and moderate certainty of evidence. The same analysis found that the effects on muscle mass and physical function were not statistically significant, with low and very low certainty respectively. That pattern, a real but modest strength benefit that only shows up alongside training, has been replicated across multiple meta analyses over the past five years, including a 2025 meta analysis of twenty trials with 1,093 older participants that found a significant improvement in one repetition maximum strength.
Everything beyond muscle is more uncertain. The cognitive evidence in older adults is small and mixed. The bone evidence contains two large null trials. The fertility and cardiovascular evidence consists mostly of pilot studies. Anyone telling you creatine is a proven anti aging compound across the board is ahead of the data, and this article will show you exactly where.
Why Aging Cells Care About Creatine at All
The mechanism is not mysterious. Cells store energy as phosphocreatine, which acts like a rapid recharge battery for ATP. When demand spikes, in a contracting muscle fiber or a firing neuron, phosphocreatine donates its phosphate to regenerate ATP faster than metabolism alone could manage. Supplementing creatine raises phosphocreatine stores in muscle reliably, and to a smaller and less predictable degree in the brain.
Aging is relevant here for a few reasons. Muscle creatine content tends to decline with age, dietary creatine intake often falls as people eat less meat and fish, and both muscle and brain energy metabolism become less efficient. A 2025 narrative review of creatine monohydrate in older adults and clinical populations lays out this rationale in detail, describing benefits on lean mass, strength, bone measures, glucose handling and cognition when creatine is combined with exercise. It is worth knowing that several authors in this field, including some on that review, have disclosed advisory relationships with creatine manufacturers. That does not invalidate the work, but it is context a careful reader should have, and it is a reason to weight independent replications heavily.
A plausible mechanism plus a real decline with age is a hypothesis, not a result. The results come next, and they do not all cooperate.
Muscle and Strength: The Best Supported Claim, With Conditions
The muscle story deserves to be told precisely, because it is often told sloppily. What the trials actually tested, almost without exception, was creatine plus a supervised resistance training program versus that same program plus placebo. Doses ranged from about 3 to 8 grams per day in most studies, sometimes with a loading phase of around 20 grams per day for five to seven days, over interventions lasting roughly 10 weeks to two years.
Under those conditions, the 2026 three level meta analysis found a small strength advantage for creatine, and its moderator analyses could not pin the benefit to any particular dose, loading strategy, duration or sex. Its authors were also careful about who the finding applies to: generally healthy older adults. They explicitly cautioned against extrapolating to frail, sarcopenic or functionally limited people, where the data are thinner.
Two honest caveats follow. First, the same analysis found no statistically significant pooled effect on muscle mass or physical function, which is not what you would expect if creatine were a powerful muscle builder in this population. Earlier analyses, such as a 2021 meta analysis of creatine ingestion strategies in older adults, did report gains in lean tissue mass alongside strength, so the literature is not unanimous, but the most methodologically conservative recent estimate is the modest one. Second, nothing in this literature supports creatine as a substitute for training. Every credible researcher in the field says the same thing: the training is the intervention, and creatine is at best a small amplifier.
On muscle, EFSA went the other way. Its 2016 opinion, later written into EU regulation 2017/672, authorized the claim that daily creatine can enhance the effect of resistance training on muscle strength in adults over 55. The conditions are precise: at least 3 grams a day, with resistance training at least three times a week for several weeks at 65 to 75 percent of the maximum weight you can lift once. EFSA noted that taking creatine only on training days didn’t produce the effect. That’s an EU authorization, not a US one, but the trials behind it hold up wherever you read them.
Brain Health and Memory: Promising, Contested, and Oversold
This is the part of the creatine for healthy aging story that gets the most attention and deserves the most skepticism, so let’s take it slowly.
The optimistic case rests on a handful of findings. A 2023 meta analysis by Prokopidis and colleagues in Nutrition Reviews pooled randomized trials of creatine and memory in healthy individuals and reported improved memory performance, with the benefit concentrated in older adults aged 66 to 76 rather than in the young. A separate 2024 meta analysis by Xu and colleagues in Frontiers in Nutrition reported improvements in memory, attention and processing speed across adult trials. And a 2026 systematic review in Nutrition Reviews focused specifically on older adults concluded there was a positive association between creatine and cognition, particularly memory and attention, while stressing that only six studies qualified for inclusion and calling the evidence sparse.
Now the inconvenient part, which most supplement blogs skip. The Prokopidis meta analysis drew a published methodological criticism from Eckert and Pascher, a letter in Nutrition Reviews describing a double counting problem: several included trials contributed multiple correlated cognitive outcomes from the same participants, which were treated as independent data points. That inflates precision and raises the risk of false positives. When the authors reanalyzed with an appropriate method, the overall memory effect was no longer significant, though the older adult subgroup finding survived. A 2026 commentary has raised the same double counting concern about the Xu meta analysis. So the two most cited positive syntheses in this field both carry documented statistical problems, and the surviving signal, memory in older adults, rests on a very small number of primary trials.
The single most rigorous null result also deserves naming. Sandkühler and colleagues published a randomized, double blind, placebo controlled crossover trial in BMC Medicine in 2023, giving healthy adults 5 grams of creatine daily for six weeks and testing reasoning and working memory as preregistered primary outcomes, plus eight exploratory tests. It found essentially nothing on the primary outcomes. The participants skewed younger than the aging population this article is about, which matters, but it remains one of the best designed trials ever run on this question and it came up empty.
Alves and colleagues published a 24 week randomized trial in 2013 in PLoS One. Fifty six women aged 60 to 80 were randomized to four groups of 14: placebo, creatine, placebo plus strength training, or creatine plus strength training. The creatine groups loaded with 20 grams a day for five days and then took 5 grams a day for the rest of the 24 weeks, which is exactly the protocol most people follow. Cognition was tested at baseline, 12 weeks, and 24 weeks with a battery covering memory, selective attention, and inhibitory control.
Creatine had no effect on any cognitive measure, at 12 weeks or 24. The Western University review rated this the only good quality study in the entire older adult literature, and it’s the one you’re least likely to hear about.
I don’t think Alves closes the question. Fourteen per group is small, the women were healthy with normal cognition, and the tests may not catch small changes in people already scoring well.
The only study to measure brain creatine and cognition together in older adults with a memory diagnosis, a 2025 open label pilot by Smith and colleagues, gave 20 people 20 grams a day for eight weeks. Brain total creatine measured by magnetic resonance spectroscopy rose about 11 percent and a composite of fluid cognition improved. With no placebo group and no blinding, the cognitive change could be practice, expectation, or chance, and the authors call it a feasibility study. What it does establish is that 20 grams a day for two months measurably raises brain creatine in older adults. A 2026 scoping review by Whitford and colleagues that searched for randomized trials in older adults with memory concerns found none at all, just this pilot and a set of animal studies, one of which reported worse spatial memory in treated rodents.
A few things are moving. Massachusetts General Hospital has registered a randomized trial of creatine in older adults around the time of surgery with brain outcomes, planned to run from late 2026 to 2028, and several smaller registered trials now measure brain creatine directly, the single most important design improvement in this field.
Then there is the regulatory verdict. In November 2024, the European Food Safety Authority evaluated a formal health claim application linking creatine to improved cognitive function and concluded that a cause and effect relationship had not been established. The panel reviewed 21 human intervention studies and noted that effects seen with short high dose protocols around 20 grams per day did not persist at the 3 gram daily dose the applicant wanted to market, that several older studies had serious methodological limitations, and that the proposed mechanism in healthy adults was weakly supported. That opinion governs claims on products sold in the EU, not in the United States, where supplement claims are policed differently by the FDA and FTC. But the science EFSA reviewed is the same science everywhere, and even Darren Candow, one of the field’s most prominent creatine researchers, publicly called the decision justified given how small the evidence base is.
Where does that leave an older adult wondering about creatine and memory? With a genuinely open question. The signal in adults over 65 is real enough that researchers keep chasing it, and biologically it makes some sense that brains with lower baseline creatine have more room to respond. But the total number of well conducted trials in older adults is in the single digits, the best positive syntheses have known statistical flaws, the best single trial was null, and a major regulator looked at everything and said not proven. That is what “promising but unestablished” actually looks like from the inside.
Fatigue Resistance and Sleep Loss: Real Effects, Wrong Dose
Some of the most eye catching creatine research of the past few years involves sleep deprivation, and it is directly relevant to fatigue resistance, one of the things people hope creatine offers as they age. It also happens to be a perfect case study in why doses matter.
In a 2024 study in Scientific Reports, Gordji-Nejad and colleagues kept fifteen healthy young adults awake for 21 hours and gave them either placebo or a single enormous dose of creatine monohydrate, 0.35 grams per kilogram of body weight, which is roughly 24 grams for a 70 kilogram person taken all at once. Using magnetic resonance spectroscopy, they observed that creatine partially preserved brain phosphocreatine and ATP measures, prevented a drop in brain pH, and reduced the deterioration in cognitive performance and processing speed that sleep loss normally causes. A 2026 follow up in Nutrients tested a lower single dose of 0.2 grams per kilogram in 29 subjects and still found reduced deterioration in logic tasks, language processing speed and psychomotor vigilance, with improvements of up to 12 percent, though the effect was weaker than at the high dose and short term memory effects appeared dose dependent.
These are careful, interesting studies. They are also studies of single acute doses, given to young sleep deprived adults, at three to seven times a normal daily supplement amount. The researchers themselves suggest that the metabolic stress of sleep deprivation is what temporarily opens the door to brain uptake. Nothing in this work shows that 5 grams a day makes a rested older adult sharper, and nobody should be taking 20 gram plus boluses as a routine habit on the strength of two small trials. If you see this research cited to sell an everyday cognitive benefit, you are watching the exact dose blurring this literature suffers from constantly.
Women, Menopause and Bone: Where Two Big Trials Found Nothing
Female health is one of the fastest growing corners of creatine research, partly because women were historically underrepresented in it. Women carry lower endogenous creatine stores than men on average, and estrogen influences energy metabolism, which is the basis for the hypothesis that the menopausal transition is a window where creatine could matter. A 2021 lifespan review by Smith-Ryan and colleagues and a 2025 update covering menstruation through menopause collect the evidence: reasonably good support for strength and exercise performance benefits in women, early and mixed signals for mood, sleep and cognition, and explicit calls for more research in perimenopause specifically, where the authors acknowledge data remain limited. A small 2025 randomized trial in 36 perimenopausal and menopausal women reported faster reaction times after eight weeks of low dose creatine hydrochloride, while another 2025 trial in a similar population found no measurable cognitive changes at all. That is where the perimenopause story currently stands: two tiny trials pointing in different directions.
The bone story is where this site’s commitment to null results earns its keep, because the null results here are substantial. Creatine was widely hypothesized to support bone, based on mechanism and smaller early studies. Then the long trials arrived. A two year randomized controlled trial by Chilibeck and colleagues in 237 postmenopausal women, published in Medicine and Science in Sports and Exercise in 2023, combined roughly 10 grams of daily creatine with a walking and resistance exercise program and found no significant effect on bone mineral density at the femoral neck, total hip or lumbar spine, contradicting the team’s own earlier one year finding, which they suggested may have been a chance result from a smaller sample. Some geometric measures of bone did improve, which is worth noting, but the primary outcome was null. Before that, Sales and colleagues ran a two year randomized placebo controlled trial of 3 grams daily in older women with low bone mass and found no benefit on bone density or physical function by any measure tested. A 2025 systematic review and meta analysis of creatine in postmenopausal women sums it up: small but real gains in lean mass and strength when creatine at 5 grams or more per day is paired with resistance training, no evidence of harm, and bone density effects that consistently span the line of no effect. If someone is selling creatine to women primarily as a bone supplement, the two best trials we have say otherwise.
Male Fertility: One Encouraging Pilot, Not a Verdict
Creatine and male reproductive health mostly circulated as a worry rather than a hope, thanks to a 2009 study in twenty rugby players that reported a rise in dihydrotestosterone, a potent androgen. That finding was never replicated, and later trials designed to test the question found no hormone differences between creatine and placebo. Most reviews of the hormonal literature count roughly ten of thirteen studies showing no meaningful testosterone change.
The more interesting recent development runs the other way. Sperm are energetically demanding cells, they naturally contain creatine and creatine kinase, and in 2025 Nedeljkovic and colleagues published a randomized controlled pilot trial giving men eight weeks of creatine, with or without ubiquinol, and tracking semen quality. In the subgroup of oligospermic men, meaning men with low sperm concentration, everyone receiving creatine showed improved sperm concentration at follow up, while concentrations in the control group stayed flat or fell, and sperm creatine content rose measurably in the combined supplement group. The authors call these findings preliminary, and they are right. It is one small pilot, in a specific subgroup, over eight weeks, and it needs replication in larger trials before anyone should treat creatine as a fertility intervention. What the current evidence does reasonably support is narrower: standard creatine doses do not appear to harm sperm parameters or hormones in healthy men, which for many people was the actual question.
The Heart: A Strong Theory Waiting for Trials
The cardiovascular case for creatine starts from solid physiology. The heart runs on the creatine kinase system, and in heart failure, myocardial creatine and the phosphocreatine to ATP ratio fall in ways that track with disease severity, as a review in Heart Failure Reviews describes. Whether that energy deficit is a cause worth correcting or a bystander remains, in that review’s own words, to be elucidated.
The human intervention evidence is thin. A 2025 Spanish pilot study gave 5 grams of creatine daily for three months to patients with heart failure and reduced ejection fraction, an open label design without a placebo group, examining functional capacity and quality of life. Reviews of the broader cardiovascular literature note scattered findings on blood pressure, microcirculation, homocysteine and inflammatory markers, alongside other studies showing minimal effects on blood flow and lipids. There is no large randomized trial showing creatine improves cardiovascular outcomes in anyone, aging or otherwise. If you have a heart condition, creatine is a conversation to have with your cardiologist, not a decision to make from a blog, including this one.
Safety, Doses, and Who Should Talk to a Doctor First
Safety is the one area where the evidence in older adults is genuinely deep. The International Society of Sports Nutrition position stand concluded that supplementation up to 30 grams per day for as long as five years has been safe and well tolerated in healthy people and many patient populations, from infants to the elderly. A 2025 safety review found no evidence of kidney harm at recommended doses of 5 to 20 grams per day, including in clinical populations studied with gold standard measures of kidney function, and found no supported link to cancer.
Two practical notes belong here. Creatine supplementation typically raises serum creatinine, a routine blood marker doctors use to estimate kidney function, because creatinine is simply creatine’s breakdown product. That can make kidney function look worse on paper without any actual damage, so tell your doctor you are taking it before you get blood work. And people with existing kidney disease, those on medications that stress the kidneys, and pregnant women are groups where evidence is limited and medical guidance beforehand is not optional.
On dosing, the studies in older adults overwhelmingly used creatine monohydrate, the cheap, generic, most researched form, at 3 to 8 grams per day, occasionally after a loading week of around 20 grams per day split into four doses. Nothing in the aging literature shows any exotic form outperforming monohydrate. In the United States, plain creatine monohydrate powder from a reputable brand typically costs somewhere around 25 to 40 cents per 5 gram dose, which is worth remembering when a premium product asks for ten times that.
What Would Change the Picture
The honest summary of creatine for healthy aging is a split verdict. Strength gains alongside resistance training: modest, real, moderate certainty. Cognition in older adults: a small, contested, genuinely interesting signal that a European regulator reviewed and declined to endorse. Bone density: two long, well run trials found nothing. Fatigue under sleep loss: real acute effects at experimental doses no one takes daily. Fertility and heart health: pilot stage.
A few things would move this field decisively. A large, preregistered randomized trial of daily creatine in adults over 65 with cognition as the primary outcome, run by a group without industry ties, would settle the question that matters most to readers of this site. Trials measuring brain creatine directly, rather than assuming muscle doses reach the brain, would tell us whether the delivery question skeptics keep raising is the real bottleneck. And replication of the fertility pilot in a larger sample would tell us whether that finding was signal or noise. Until then, the reasonable position for a healthy older adult is that creatine monohydrate is inexpensive, well characterized, and clearly useful if you are training for strength, possibly useful for the brain, and not yet proven for the rest. That is less exciting than the headlines. It also has the advantage of being true.